Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Gary Meyer"'
Autor:
Jeeyun Lee, Sung Kim, Phillip Kim, Xinjun Liu, Tani Lee, Kyoung-Mee Kim, In-Gu Do, Joon Oh Park, Se Hoon Park, Jiryeon Jang, Nicholas Hoe, Gulia Harvie, Anne Kuller, Anjali Jain, Gary Meyer, Glen Leesman, Young Suk Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Ho Yeong Lim, Sharat Singh, Won Ki Kang
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54644 (2013)
The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs).Protein lysates from fresh-frozen 434
Externí odkaz:
https://doaj.org/article/e271a8bf163e483ea10b893e95bb5eb8
Winner of the Distinguished Book Award by the Applied Communication Division of the National Communication Association, 2001 Effective Health Risk Messages provides step-by-step instructions for developing theoretically based campaigns that work. Rea
Autor:
Thomas A Abrams, Gary Meyer, Lisa M Hess, Sui Zhang, Astra M Liepa, Yajun Zhu, Jeffrey A Meyerhardt, Deborah Schrag, Peter C Enzinger, Charles S Fuchs
Publikováno v:
Journal of Clincal Pathways. 7
Autor:
Dengfeng Cao, Feng Gao, Andrea Wang-Gillam, Faris Murad, Lin Li, Sharat Singh, Steven A. Edmundowicz, Riad R. Azar, P. Kim, Dayna S. Early, Jingqin Luo, Kian-Huat Lim, Daniel Mullady, Gary Meyer, Sachin Wani, Emma Langley, Vladamir M. Kushnir
Publikováno v:
Oncotarget
// Kian-Huat Lim 1 , Emma Langley 5 , Feng Gao 4 , Jingqin Luo 4 , Lin Li 1 , Gary Meyer 5 , Phillip Kim 5 , Sharat Singh 5 , Vladamir M. Kushnir 2 , Dayna S. Early 2 , Daniel K. Mullady 2 , Steven A. Edmundowicz 6 , Sachin Wani 6 , Faris M. Murad 7
Autor:
Samuel A. Jacobs, S. Rim Kim, KL Pogue-Geile, JP Michel, Emma Langley, Ashok Srinivasan, Phillip Kim, Gary Meyer, C Lipchick, Patrick G. Gavin, Huichen Feng
Publikováno v:
Cancer Research. 77:P1-07
The NSABP FB-7 trial enrolled HER2-positive breast cancer patients (pts) with locally advanced disease who were randomly assigned to trastuzumab (T) or neratinib (N) or the combination (T+N) with weekly paclitaxel (P) followed by standard AC. A total
Autor:
Gary Meyer, Deborah Schrag, Jeffrey A. Meyerhardt, Brian M. Wolpin, Charles S. Fuchs, Thomas A. Abrams
Purpose Few population studies have examined patterns of systemic therapy administration in metastatic pancreatic cancer (MPC) or the predictors associated with specific treatment choices. Patients and methods We assessed 4,011 consecutive MPC patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0230f1955a923a76543ca244077281
https://europepmc.org/articles/PMC5553956/
https://europepmc.org/articles/PMC5553956/
Publikováno v:
Color and Imaging Conference. 20:170-176
Publikováno v:
Color and Imaging Conference. 19:160-165
Autor:
Jeffrey A. Meyerhardt, Peter C. Enzinger, Yajun Zhu, Sui Zhang, Charles S. Fuchs, Lisa M. Hess, Astra M. Liepa, Deborah Schrag, Gary Meyer, Thomas A. Abrams
Publikováno v:
Journal of Clinical Oncology. 36:112-112
112 Background: MGC is associated with poor survival outcomes. Despite multiple therapeutic options, there is no clearly defined standard-of-care (SOC) CT algorithm. Assessing MGC treatment trends of CT utilization is of critical import. Few populati
Publikováno v:
Conference on Colour in Graphics, Imaging, and Vision. 4:132-137